NIH takes action after Scrip report on unapproved drug postings
This article was originally published in Scrip
Executive Summary
The National Institutes of Health (NIH) worked quickly over the weekend to update its PubMed Health consumer website after Scrip reported 3 March that the site listed brandname drugs not approved by the US FDA along with directions for use and other advice about those products.